Magnus Corfitzen

Magnus Corfitzen Email and Phone Number

Ceo At Ascelia Pharma Ab @ Ascelia Pharma AB

Magnus Corfitzen's Contact Details

Magnus Corfitzen personal email

n/a

Magnus Corfitzen's Current Company Details

Ascelia Pharma Ab

Ceo At Ascelia Pharma Ab

Magnus Corfitzen Work Experience Details

  • Ceo
    Ascelia Pharma Ab 2017 - Present
    Malmö, Skane County, Se
    Ascelia is a specialty pharmaceutical company located in Malmö, Sweden dedicated to the development of novel medicines to improve the life expectancy and quality of life for people living with cancer. The Company’s strategy is to develop and make available to patients a portfolio of differentiated, underappreciated and de-risked medicinal product candidates addressing unmet medical needs in cancer and cancer-related diseases.Ascelia has two clinical stage product candidates under development: Mangoral and Oncoral.
  • Ceo
    Ascelia Pharma Ab Jul 2014 - 2017
    Malmö, Skane County, Se
    CMC Contrast AB is a privately owned biotech company developing CMC-001, a novel liver MRI contrast agent for use in patients at risk of serious side effects from gadolinium based contrast agents. The drug has been tested in 6 clinical studies and has orphan drug designation from FDA.
  • Investment Director - Life Science Ventures
    Sunstone Life Science Ventures May 2007 - Jun 2014
    Copenhagen, Capital Region, Dk
    Sunstone Capital is a European venture capital firm founded in 2007 and has approximately EUR 700 million under management.
  • Interim Ceo
    Cmc Contrast Ab 2011 - Apr 2012
    Malmö, Skane County, Se
    CMC Contrast AB is a privately owned drug development company developing CMC-001, a novel contrast agent for use in liver MRI in patients where gadolinium based contrast agents are contraindicated or cannot be administered due to risk of serious side effects such as Nephrogenic Systemic Fibrosis.
  • Investment Director - Life Science Ventures
    Vaekstfonden Nov 2002 - May 2007
    Copenhagen, Capital Region Of Denmark, Dk
    Vaekstfonden is a EUR 400 million state owned investment fund investing in early stage companies.
  • Portfolio Manager Biotechnology And Medtech
    Danske Bank Aug 2000 - Oct 2002
    Copenhagen, Capital Region Of Denmark, Dk
    Danske Capital is the asset management division of the Danske Bank group with EUR 50 billion under management.
  • Consultant
    Mckinsey & Company May 1999 - Jun 2000
    Us
    McKinsey & Company is a global management consulting firm advising the world's leading businesses, governments and institutions.

Magnus Corfitzen Education Details

  • Aarhus University
    Mathematical Economics
  • Harvard University
    Corporate Governance & International Business

Other Similar Profiles

View similar profiles

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.

Frequently Asked Questions about Magnus Corfitzen

What company does Magnus Corfitzen work for?

Magnus Corfitzen works for Ascelia Pharma Ab

What is Magnus Corfitzen's role in his/her workplace?

Magnus Corfitzen's role in his/her workplace is Ceo At Ascelia Pharma Ab.

What is Magnus Corfitzen's email address?

Magnus Corfitzen's email address is co****@****tal.com

What schools did Magnus Corfitzen attend?

Magnus Corfitzen attended Aarhus University, and Harvard University .

What is Magnus Corfitzen's role in his/her workplace?

Magnus Corfitzen has skills like Venture Capital, Start Ups, Strategy, Due Diligence, Biotechnology, Investments, Business Strategy, Pharmaceutical Industry, Business Development, Financial Modeling, Life Sciences, Medical Devices, Corporate Development, Market Analysis, Private Equity, Entrepreneurship, Mergers And Acquisitions, Portfolio Management, Lifesciences, Capital Markets, Valuation, Growth Capital, Commercialization, Corporate Finance, M&a Experience, Asset Management, Venture Financing, Finance, Drug Development, Emerging Markets, Investor Relations, Negotiation, Ipo, Biotechnology Industry, Angel Investing, Restructuring, Orphan Drugs, and Regulatory Strategy Development.

Who are the industry peers of Magnus Corfitzen at other companies?

Magnus Corfitzen's peers at other companies are Hans T. Schambye, Andreas L Norlin, Lauren (Geyer) Barnes, Julie Waras Brogren, Søren Bregenholt, and Henrik Blou. and Nadilka Hettiarachchige. Magnus Corfitzen's peers at other companies are Hans T. Schambye, Andreas L Norlin, Lauren (Geyer) Barnes, Julie Waras Brogren, Søren Bregenholt, and Henrik Blou. and Nadilka Hettiarachchige.